Pharvaris b.v.

Major-Pharmaceuticals

PHVS


Executive/
Director

Price

  • Last Close
  • $ 18.73
    $ +0.4 2.18 %
    Jan 3, 2025
  • 52-Week High/Low
  • $32.07 - $15.2
  • YTD
  • -3.8%

  • Trading Volume
  • 9,749
  • Market Cap Full
  • $ 633.4M
  • Shares Outstanding
  • 33.8M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - - - 26% -30.5% -18.1% -3.8%
Q2 - - - - - -33.4% 21.9% 100.9% -16.7% -
Q3 - - - - - -4.8% -65.3% 32.9% 0.2% -
Q4 - - - - - -18.8% 46.7% 51.6% 5.1% -
J F M A M J J A S O N D
2025 -3.8% - - - - - - - - - - -
2024 6.6% -23.3% 0.2% -17.1% 0.6% -6.2% -4.1% 0.2% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%0%-22%149%-31%-4%

Earnings

2021 2022 2023
Q1 -0.8 -0.54 -0.72
Q2 -1.13 -0.4 -0.69
Q3 -0.46 -0.25 -0.63
Q4 0.73 -1.20 -
A -1.7 -2.39 -2.04

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022
Mar - - -
Jun - - -
Sep - - -
Dec 4.9 33.2 33.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 8.3 4.9 -29 - -
Equity multiplier - - - - -